Doctors Urge Use of Aspirin for Colorectal Cancer and Cardiovascular Patients
For decades, low-dose aspirin has been a popular supplement to help reduce the risk of heart attacks and stroke. Researchers are now examining this common medication for its ability to also reduce the risks of colorectal cancer and cardiovascular disease.
Researchers under the direction of the U.S. Preventive Services Task Force (USPSTF) looked at three systemic evidence reviews of the health benefits of aspirin. The reviews showed that the majority of study participants who started a standard use of aspirin between ages 50-69 had an overall better quality of life or decrease in illness.
The USPSTF encourages patients ages 50-69 who have a 10 percent or higher risk of developing cardiovascular disease within the next 10 years to talk with their doctor about starting a low-dose aspirin treatment.
Before going on an aspirin regimen, doctors should assess the patients for bleeding risk and also ensure that they can maintain the dose for at least 10 years. The USPSTF believes that as long as there is no risk of bleeding, aspirin treatment should reduce the risk of cardiovascular disease and colorectal cancer.
More research is necessary to determine if the medication has substantial benefits for people under the age of 50 or older than 70 years of age. The USPSTF is quick to remind patients and doctors that regular follow-ups and monitoring for internal bleeding is necessary while on an aspirin regimen.
Help is Available if You Suffer from a Disabling Condition
Conditions like cardiovascular disease and colorectal cancer can prevent you from working and earning a substantial income. If you can no longer work and need financial assistance, the Disability Help Group can assist you. For help filing for Social Security disability benefits and appealing denied applications, contact us at 800-800-2009 to schedule a consultation with our disability advocates.